Neurology-多发性硬化预后,或与种族相关

2021-07-12 Freeman MedSci原创

多发性硬化预后,或与种族相关

临床观察和新出现的研究表明,患有多发性硬化症(MS)的美国黑人(BA)往往比他们的美国白人(WA)同行的情况更糟糕。以前的研究表明,相对于美国白人而言,患有多发性硬化症的BA的疾病负担更重。

研究报告称,与美国白人相比,BAs的残疾积累更多,更早发展到需要流动协助,脑部MRI上的病变积累更快,脑部和视网膜组织损失更快,视神经炎后高对比度视力损失更多。

尽管有这些报道,已发表的研究在知识方面产生了一些差距,部分是由于研究设计和方法的局限性。较大的研究主要是回顾性的,集中在对残疾的全面测量(即扩展的残疾状态量表[EDSS],多发性硬化症严重程度评分[MSSS]),这些半定量的量表主要是评估移动功能。

许多评估其他结果的研究,特别是大脑或视网膜萎缩的研究,BA的样本很小,或者是单中心研究,因此,估计的精确度以及所研究的病人的代表性是令人担忧的。此外,种族与社会经济地位的交集是一个已知的决定健康的有力因素,因为它与多发性硬化症的结果有关,在美国的人群中还没有得到很好的描述。

为了解决之前研究的这些缺陷,霍普金斯大学的Karla Gray-Roncal等人,在美国的BA和WA多发性硬化症患者的大型多中心队列中,全面比较了神经功能和疾病严重程度,并评估种族和社会经济地位与这些措施之间的相互作用。

方法。他们比较了多发性硬化队列(MS PATHS)队列中的BA和WA参与者,在协变量调整(包括教育水平、就业或保险作为社会经济指标)后,MS特征包括自我报告的残疾、客观的神经功能评估和定量的脑MRI测量。在亚组中,他们使用9位数的邮政编码评估了种族内、邻里层面的社会经济地位(SES)指标。

他们发现,在1,214名BA和7,530名WAs患者中,BA更年轻,教育水平更低,比WAs更可能有医疗补助保险或残疾或失业。

BAs自我报告的残疾情况更差(重度残疾与轻度残疾的几率大1.47倍,95% CI 1.18, 1.86),在认知处理速度(正确率降低5.06,CI -5.72, -4.41)、行走(慢0.66秒,95% CI 0.36, 0.96)和手工灵活性(慢2.11秒,95% CI 1.69, 2.54)的测试中表现更糟。

BAs有更多的脑部MRI病变,整体和灰质脑容量较低,包括丘脑(-0.77毫升,95%CI-0.91,-0.64)、皮质(-30.63毫升,95%CI-35.93,-25.33)和深层(-1.58毫升,95%CI-1.92,-1.23)灰质容量减少。

虽然较低的SES与WA中较差的神经表现分数相关,但这种关联在BA中却不太明显。

这个研究的重要意义,在于发现了:相对于WAs的MS,BAs的疾病负担更大。除了SES,未来的纵向研究还应该考虑其他社会结构的作用。这类研究对于确定预后因素和患有多发性硬化症的BAs的最佳治疗策略,意义重大。

原文出处:
Gray-Roncal K, Fitzgerald K, Ryerson LZ, Charvet L, Cassard SD, Naismith R, Ontaneda D, Mahajan K, Castro-Borrero W, Mowry E. Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis. Neurology. 2021 Jun 30:10.1212/WNL.0000000000012362. doi: 10.1212/WNL.0000000000012362. Epub ahead of print. PMID: 34193590.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1890275, encodeId=ee6a18902e5e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Mon Aug 30 21:39:40 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001400, encodeId=36b320014009c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat May 21 15:39:40 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179428, encodeId=8f1511e94283a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:12:33 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998736, encodeId=dbc5998e3649, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:03:47 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998683, encodeId=8a8e998683bd, content=生而不同~, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Jul 12 06:48:35 CST 2021, time=2021-07-12, status=1, ipAttribution=)]
    2021-08-30 jml2009
  2. [GetPortalCommentsPageByObjectIdResponse(id=1890275, encodeId=ee6a18902e5e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Mon Aug 30 21:39:40 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001400, encodeId=36b320014009c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat May 21 15:39:40 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179428, encodeId=8f1511e94283a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:12:33 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998736, encodeId=dbc5998e3649, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:03:47 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998683, encodeId=8a8e998683bd, content=生而不同~, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Jul 12 06:48:35 CST 2021, time=2021-07-12, status=1, ipAttribution=)]
    2022-05-21 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1890275, encodeId=ee6a18902e5e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Mon Aug 30 21:39:40 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001400, encodeId=36b320014009c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat May 21 15:39:40 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179428, encodeId=8f1511e94283a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:12:33 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998736, encodeId=dbc5998e3649, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:03:47 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998683, encodeId=8a8e998683bd, content=生而不同~, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Jul 12 06:48:35 CST 2021, time=2021-07-12, status=1, ipAttribution=)]
    2021-12-31 1491450296

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1890275, encodeId=ee6a18902e5e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Mon Aug 30 21:39:40 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001400, encodeId=36b320014009c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat May 21 15:39:40 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179428, encodeId=8f1511e94283a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:12:33 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998736, encodeId=dbc5998e3649, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:03:47 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998683, encodeId=8a8e998683bd, content=生而不同~, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Jul 12 06:48:35 CST 2021, time=2021-07-12, status=1, ipAttribution=)]
    2021-07-12 1e22b426m70(暂无匿称)

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1890275, encodeId=ee6a18902e5e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Mon Aug 30 21:39:40 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001400, encodeId=36b320014009c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat May 21 15:39:40 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179428, encodeId=8f1511e94283a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec24659817, createdName=1491450296, createdTime=Fri Dec 31 22:12:33 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998736, encodeId=dbc5998e3649, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Mon Jul 12 11:03:47 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998683, encodeId=8a8e998683bd, content=生而不同~, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Jul 12 06:48:35 CST 2021, time=2021-07-12, status=1, ipAttribution=)]
    2021-07-12 学医无涯

    生而不同~

    0

相关资讯

Neurology:多发性硬化者,功能网络连接可反应认知功能减退

多发性硬化者,功能网络连接可反应认知功能减退

Multiple Sclerosis Journal:脑桥周围病变的定位是鉴别MS与小血管病的良好指标

脑桥周围病变的定位是鉴别MS与小血管病的良好指标。

JNNP-灰质的体积模式,可有效预测多发性硬化的进展

灰质的体积模式,可有效预测多发性硬化的进展

Neurol Neuroimmunol Neuroinflamm:组织谷氨酰胺酶表达与多发性硬化的进展有关

PBMCs来源的TG2 mRNA水平与多发性硬化疾病进展的临床和放射学测量相关,因此有望作为多发性硬化特别是PP多发性硬化患者疾病进展的生物标志物。

Neurol Neuroimmunol Neuroinflamm: 结构和功能MRI网络可预测多发性硬化症临床恶化

该研究发现整合结构和功能MRI网络措施改善了对临床恶化的预测。

Ann Neurol-多发性硬化症,肠道菌群“作用”非同一般

多发性硬化症,肠道菌群“作用”非同一般